Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

Gamaleya Center starts testing its anti-COVID medicine based on monoclonal antibodies

Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on monoclonal antibodies, the center’s chief...

Gamaleya Center can develop COVID-19 vaccine based on several strains

Deputy director of the center Denis Logunov specified that a part of the vaccine based on the Wuhan or Delta strain will be able...

South Korea to spend $5.3 billion for corporate investment in vaccine development

Finance Minister Hong Nam-ki said Thursday the government plans to spend 6.3 trillion won (US$5.3 billion) to support corporate facility investment in vaccine development...

Nigeria is working to develop a COVID-19 vaccine, President Muhammadu Buhari said

Health experts say Nigeria needs to triple its vaccination drive from just over 100,000 doses a day to meet its target of inoculating more...

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop mRNA-based Vaccine

Pfizer Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of...

Russia develops testing system capable of detecting Omicron coronavirus variant

A testing system capable of simultaneously detecting the coronavirus genome and deciding if it is the Omicron variant of the virus has been developed...
spot_img

Expert Articles

spot_img